Tisch Cancer Institute/Icahn School of Medicine at Mount Sinai

New York, New York 10029

2 studies enrolling now · 4 studies all time

What they study most

Advanced Cancers (Breast, Ovarian, mCRPC, Pancreatic Ductal Adenocarcinoma (PDAC), Brain Mets) With Specific Mutations (Homologous Recombination Deficiency), Breast Cancer, Cervical Cancer, Colorectal Cancer, Endometrial Cancer, Esophageal Cancer, Gastric Cancer, Head and Neck Squamous Cell Carcinoma HNSCC, Non-Small Cell Lung Cancer NSCLC, Pancreatic Ductal Adenocarcinoma (PDAC), Urothelial Cancer

Studies at this site

• A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer — Recruiting now
• Study to Assess Safety, Tolerability and Activity of DSB2455 in Participants With Advanced Malignancies — Recruiting now
• Phase II Trial of Combination Immunotherapy With NeuVax and Trastuzumab in High-risk HER2+ Breast Cancer Patients — Completed
• Combination Immunotherapy With Herceptin and the HER2 Vaccine NeuVax — Completed